Trellus Management Company’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-127,000	Closed	-$281K	–	77
2023 Q2	$281K	Hold	127,000	–	–	0.35%	48
2023 Q1	$323K	Sell	127,000 -168,000	-57%	-$427K	0.38%	35
2022 Q4	$552K	Hold	295,000	–	–	0.7%	23
2022 Q3	$758K	Hold	295,000	–	–	0.92%	14
2022 Q2	$569K	Hold	295,000	–	–	0.69%	24
2022 Q1	$876K	Hold	295,000	–	–	0.51%	20
2021 Q4	$1.33M	Hold	295,000	–	–	0.88%	15
2021 Q3	$1.43M	Buy	295,000 +10,600	+4%	+$51.5K	1.04%	21
2021 Q2	$1.94M	Sell	284,400 -55,600	-16%	-$379K	1.34%	15
2021 Q1	$2.4M	Hold	340,000	–	–	1.24%	10
2020 Q4	$2.13M	Buy	340,000 +40,000	+13%	+$250K	1.76%	10
2020 Q3	$1.62M	Hold	300,000	–	–	1.66%	13
2020 Q2	$1.57M	Buy	300,000 +72,300	+32%	+$377K	1.7%	12
2020 Q1	$717K	Buy	227,700 +80,645	+55%	+$254K	1.29%	27
2019 Q4	$593K	Sell	147,055 -37,945	-21%	-$153K	0.99%	30
2019 Q3	$799K	Buy	185,000 +20,000	+12%	+$86.4K	0.8%	23
2019 Q2	$658K	Buy	165,000 +65,000	+65%	+$259K	0.89%	32
2019 Q1	$536K	Buy	100,000 +28,800	+40%	+$154K	1.02%	31
2018 Q4	$365K	Sell	71,200 -28,800	-29%	-$148K	0.82%	32
2018 Q3	$970K	Hold	100,000	–	–	1.4%	19
2018 Q2	$1.02M	Buy	100,000 +10,300	+11%	+$105K	1.5%	16
2018 Q1	$1.17M	Buy	89,700 +49,700	+124%	+$646K	2.12%	16
2017 Q4	$716K	Buy	40,000 +20,000	+100%	+$358K	0.98%	23
2017 Q3	$502K	Buy	+20,000	New	+$502K	0.69%	35